Joyzyme Group Limited (HKG:8622)
0.3450
+0.0200 (6.15%)
Apr 2, 2026, 4:08 PM HKT
Joyzyme Group Revenue
In the year 2025, Joyzyme Group had annual revenue of 28.28M CNY with 11.53% growth. Joyzyme Group had revenue of 15.95M in the half year ending December 31, 2025, with 21.19% growth.
Revenue
28.28M CNY
Revenue Growth
+11.53%
P/S Ratio
5.65
Revenue / Employee
288.59K CNY
Employees
98
Market Cap
177.84M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.28M | 2.92M | 11.53% |
| Dec 31, 2024 | 25.36M | 730.00K | 2.96% |
| Dec 31, 2023 | 24.63M | -701.00K | -2.77% |
| Dec 31, 2022 | 25.33M | -797.00K | -3.05% |
| Dec 31, 2021 | 26.13M | 4.16M | 18.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.08B |
| Kontafarma China Holdings | 914.71M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Qianhai Health Holdings | 677.12M |
| PuraPharm Corporation | 336.11M |
| Tianda Pharmaceuticals | 322.95M |
| Sanai Health Industry Group Company | 104.88M |